Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease
Overview
Chemistry
Molecular Biology
Affiliations
Cellular identity is determined through complex patterns of gene expression. Chromatin, the dynamic structure containing genetic information, is regulated through epigenetic modulators, mainly by the histone code. One of the main challenges for the cell is maintaining functionality and identity, despite the accumulation of DNA damage throughout the aging process. Replicative cells can remain in a senescent state or develop a malign cancer phenotype. In contrast, post-mitotic cells such as pyramidal neurons maintain extraordinary functionality despite advanced age, but they lose their identity. This review focuses on tau, a protein that protects DNA, organizes chromatin, and plays a crucial role in genomic stability. In contrast, tau cytosolic aggregates are considered hallmarks of Alzheimer´s disease (AD) and other neurodegenerative disorders called tauopathies. Here, we explain AD as a phenomenon of chromatin dysregulation directly involving the epigenetic histone code and a progressive destabilization of the tau-chromatin interaction, leading to the consequent dysregulation of gene expression. Although this destabilization could be lethal for post-mitotic neurons, tau protein mediates profound cellular transformations that allow for their temporal survival.
Is O, Min Y, Wang X, Oatman S, Abraham Daniel A, Ertekin-Taner N Glia. 2024; 73(3):539-573.
PMID: 39652363 PMC: 11784841. DOI: 10.1002/glia.24652.
Exploring the neuroprotective potential of Nrf2-pathway activators against annonacin toxicity.
Costa M, Rosler T, Hoglinger G Sci Rep. 2024; 14(1):20123.
PMID: 39209951 PMC: 11362529. DOI: 10.1038/s41598-024-70837-1.
Nuclear face of Tau: an inside player in neurodegeneration.
Younas N, Saleem T, Younas A, Zerr I Acta Neuropathol Commun. 2023; 11(1):196.
PMID: 38087392 PMC: 10714511. DOI: 10.1186/s40478-023-01702-x.
Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.
Sun X, Eastman G, Shi Y, Saibaba S, Oliveira A, Lukens J Alzheimers Dement. 2023; 20(3):1656-1670.
PMID: 38069673 PMC: 10947977. DOI: 10.1002/alz.13535.
Valles-Saiz L, Avila J, Hernandez F Int J Mol Sci. 2023; 24(13).
PMID: 37446327 PMC: 10342792. DOI: 10.3390/ijms241311144.